Drug Information

Drug General Information
Drug ID
D0D1GF
Former ID
DCL000265
Drug Name
XL880
Synonyms
GSK 089; GSK 1363089; GSK1363089; XL 880; GSK1363089, GSK089, foretinib, EXEL-2880, XL880; 88Z; MET inhibitors
Drug Type
Small molecular drug
Indication Gastric cancer; Renal cell carcinoma; Squamous cell cancer of head and neck [ICD9: 140-229, 151, 189; ICD10:C16, C64] Phase 2 [541022], [550637]
Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [541022], [550637]
Therapeutic Class
Anticancer Agents
Company
Exelixis; GlaxoSmithKline
Structure
Download
2D MOL

3D MOL
Formula
C34H34F2N4O6
InChI
InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)
InChIKey
CXQHYVUVSFXTMY-UHFFFAOYSA-N
PubChem Compound ID
42642645
PubChem Substance ID
81082087, 86465340, 93375504, 99436987, 104246801, 123055389, 124490358, 124757009, 125163814, 125329934, 126731542, 131480687, 134338922, 134964398, 135257201, 135727454, 136367309, 136367948, 136920382, 137245315, 137275745, 137275948, 137760554, 143499560, 144115968, 152043738, 152234432, 152258182, 152344218, 160647018, 162011882, 162037444, 162196274, 163348564, 164041883, 170501826, 172913907, 174530915, 177748909, 178102306, 185997073, 185998158, 186000980, 188899550, 198948852, 198993146, 223387910, 223704673, 224083490, 226703719
Target and Pathway
Target(s) Vascular endothelial growth factor receptor 2 Target Info Modulator [1572591]
Hepatocyte growth factor receptor Target Info Modulator [1572591]
KEGG Pathway Ras signaling pathway
Rap1 signaling pathway
Cytokine-cytokine receptor interaction
Endocytosis
PI3K-Akt signaling pathway
VEGF signaling pathway
Focal adhesion
Proteoglycans in cancerhsa04014:Ras signaling pathway
Axon guidance
Adherens junction
Bacterial invasion of epithelial cells
Epithelial cell signaling in Helicobacter pylori infection
Malaria
Pathways in cancer
Transcriptional misregulation in cancer
Proteoglycans in cancer
MicroRNAs in cancer
Renal cell carcinoma
Melanoma
Central carbon metabolism in cancer
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway Angiogenesis
VEGF signaling pathway
Pathway Interaction Database HIF-2-alpha transcription factor network
Beta3 integrin cell surface interactions
Signaling events mediated by TCPTP
SHP2 signaling
S1P1 pathway
VEGF and VEGFR signaling network
Integrins in angiogenesis
Signaling events mediated by VEGFR1 and VEGFR2
Notch-mediated HES/HEY networkmet_pathway:Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
Arf6 signaling events
Posttranslational regulation of adherens junction stability and dissassembly
Direct p53 effectors
Syndecan-1-mediated signaling events
Stabilization and expansion of the E-cadherin adherens junction
a6b1 and a6b4 Integrin signaling
FGF signaling pathway
Regulation of retinoblastoma protein
Reactome Neurophilin interactions with VEGF and VEGFR
VEGF binds to VEGFR leading to receptor dimerization
Integrin cell surface interactions
EPHA-mediated growth cone collapse
VEGFA-VEGFR2 Pathway
VEGFR2 mediated cell proliferationR-HSA-416550:Sema4D mediated inhibition of cell attachment and migration
WikiPathways Focal Adhesion
Nifedipine Activity
Cardiac Progenitor Differentiation
Signaling by VEGF
AngiogenesisWP366:TGF beta Signaling Pathway
Signaling of Hepatocyte Growth Factor Receptor
Extracellular vesicle-mediated signaling in recipient cells
Signaling Pathways in Glioblastoma
miR-targeted genes in squamous cell - TarBase
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in epithelium - TarBase
Semaphorin interactions
References
Ref 541022(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5679).
Ref 550637Clinical pipeline report, company report or official report of Exelixis (2011).
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.